LumiraDx Investor Presentation Deck

COVID Example: Comprehensive Portfolio from Lab to Home RNA STAR Open Molecular Systems SA Compl 6 INA STAR Reference Labs Innovative qSTAR technology Single step method on open channel PCR systems Ⓒ Results in 20 minutes Up to 1000 tests/hour/machine Indications for asymptomatic, pooling and sample home collection lumiraDx™ • Detects omicron with equivalent sensitivity to other variants Antigen/Antibody LumiraDx Platform 1000 SUSCINE Ab 101 LASA POC Labs Microfluidic technology High sensitivity antigen test: Ⓒ 97.6% PPA with RT-PCR up to 12 DSO Ⓒ Effectively detects VOCS • Detects Omicron with equivalent sensitivity to other variants Ⓒ 5 min COVID Ultra achieved CE Mark, Europe launch in Q3(2) Antigen Pool(1) LumiraDx Platform PumunoDx POOL TEST SARS-COM-2 Ag Professional-Led Screening • Microfluidic technology Enables pooling of 5 samples on a single test strip, with high sensitivity High throughput at low cost Pooling and deconvolution on single POC Platform Detects Omicron with equivalent sensitivity to other variants Decentralization (1) LumiraDx SARS-CoV-2 Antigen Pool and Amira POC test are available under CE Mark only; not available in the US. (2) COVID Ultra in development for US market and subject to FDA review. Copyright ©2022 Lumirax Ltd. All Rights Reserved. Worldwide Antigen Amira System(1) amira COVID-19 T meng Haders Mod (comezabal BREATED Ragg Home/Consumer Venues Microfluidic technology High sensitivity, low cost. connected antigen test Screening and self-test applications Ⓒ Amira POC test achieved CE Mark 39

View entire presentation